Published on : Mar 29, 2017
Albany, New York, March 29, 2017: ResearchMoz.us has announced the addition of a new market intelligence report to its repository. The report is titled, “Global Coagulation Testing Market 2017-2021.” The study examines the growth of the market followed over the last few years and the prospects of growth in the near future. The research report details out the causes accountable for the variations in the market and analyses them thoroughly. The impact of certain trends has also been discussed in the report. It further provides data on the market shares, strategies, and products of leading companies.
Coagulation testing enables to measure the capability of blood to turn into a clot. Clotting happens when blood gets converted to a gel form from liquid. Coagulation tests are done to evaluate clotting disorders such as thrombosis and hemorrhage. Several types of coagulation tests are found such as bleeding time, thrombin time, platelet count, prothrombin time, fibrinogen level, and V assay. Coagulation testing evaluators play a crucial role in enhancing the quality of patients’ life.
Click to get more details with TOC in a PDF Format: http://www.researchmoz.us/enquiry.php?type=S&repid=964324
According to the report, the coagulation testing market is expected to rise at a CAGR over 6% over the forecast period. The rising penetration of point-of-care testing (POCT) equipment in developed economies is expected to drive the growth of the global coagulation testing market. One of the primary factors influencing the rising demand for POCT coagulation equipment is the favourable reimbursement system in Europe and its rising adoption in the region.
On the basis of application, the global coagulation market can be segmented into ACT, TT, PT, and aPTT. The segment of prothrombin time (PT) emerged dominant in 2016 and is likely to maintain a led until the end of the forecast period. The growth of this segment can be attributed to its high sensitivity because of which its demand is increasing. In terms of end user, the market is classified into home care and hospitals and private clinics. The segment of hospitals and private clinics led the market in 2016 and is expected to dominate the market until 2021. One of the primary factors triggering this segments growth is the growing hospitalization of patients for serious cases.
Geographically, the Americas led the market in 2016 and is expected to retain dominance over the forecast period. The factor triggering the growth of the market in this region is the growing geriatric population and rising incidences of myocardial infractions, stroke, and pulmonary embolisms. Vendors are focusing on marketing strategies and product development to establish a leading position in the market. The key players in the market are Siemens Healthcare, Abbott Laboratories, Alere, and Roche Diagnostics.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org